Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001384101-22-000007
Filing Date
2022-01-13
Accepted
2022-01-13 16:47:33
Documents
2
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164211043813715.html 3  
1 FORM 3 wf-form3_164211043813715.xml 3 7559
2 EXHIBIT 24 - TINA NOVA section16poavcyt-tinanova.htm EX-24 7144
  Complete submission text file 0001384101-22-000007.txt   16372
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Nova Tina Susan (Reporting) CIK: 0001302605 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36156 | Film No.: 22529552

Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories